Ophthalmic Lasers - Medical Devices Pipeline Assessment, 2017

  • ID: 4315739
  • Report
  • 124 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 3D-Micromac AG
  • Bausch + Lomb Technolas
  • Carl Zeiss Meditec AG
  • Lensar Inc
  • MRC Systems GmbH
  • Rowiak GmbH
  • MORE
Ophthalmic Lasers - Medical Devices Pipeline Assessment, 2017

Summary

The analyst's Medical Devices sector report, “Ophthalmic Lasers - Medical Devices Pipeline Assessment, 2017" provides an overview of Ophthalmic Lasers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Lasers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Ophthalmic Lasers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ophthalmic Lasers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ophthalmic Lasers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3D-Micromac AG
  • Bausch + Lomb Technolas
  • Carl Zeiss Meditec AG
  • Lensar Inc
  • MRC Systems GmbH
  • Rowiak GmbH
  • MORE
1 Table of Contents
2 Introduction
2.1 Ophthalmic Lasers Overview
3 Products under Development
3.1 Ophthalmic Lasers - Pipeline Products by Stage of Development
3.2 Ophthalmic Lasers - Pipeline Products by Segment
3.3 Ophthalmic Lasers - Pipeline Products by Territory
3.4 Ophthalmic Lasers - Pipeline Products by Regulatory Path
3.5 Ophthalmic Lasers - Pipeline Products by Estimated Approval Date
3.6 Ophthalmic Lasers - Ongoing Clinical Trials
4 Ophthalmic Lasers - Pipeline Products under Development by Companies
4.1 Ophthalmic Lasers Companies - Pipeline Products by Stage of Development
4.2 Ophthalmic Lasers - Pipeline Products by Stage of Development
5 Ophthalmic Lasers Companies and Product Overview
5.1 3D-Micromac AG Company Overview
5.1.1 3D-Micromac AG Pipeline Products & Ongoing Clinical Trials Overview
5.2 Alcon Inc Company Overview
5.2.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Bausch & Lomb Inc Company Overview
5.3.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Bausch + Lomb Technolas Company Overview
5.4.1 Bausch + Lomb Technolas Pipeline Products & Ongoing Clinical Trials Overview
5.5 Belkin Laser Ltd Company Overview
5.5.1 Belkin Laser Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Biolase, Inc. Company Overview
5.6.1 Biolase, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Carl Zeiss Meditec AG Company Overview
5.7.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview
5.8 CV Laser Pty Ltd Company Overview
5.8.1 CV Laser Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Ellex Medical Lasers Limited Company Overview
5.9.1 Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview
5.10 IOPtima Ltd. Company Overview
5.10.1 IOPtima Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.11 Lensar Inc Company Overview
5.11.1 Lensar Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 LumiThera, Inc. Company Overview
5.12.1 LumiThera, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Massachusetts Eye and Ear Infirmary Company Overview
5.13.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
5.14 Michigan State University Company Overview
5.14.1 Michigan State University Pipeline Products & Ongoing Clinical Trials Overview
5.15 MRC Systems GmbH Company Overview
5.15.1 MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.16 Nidek Co Ltd Company Overview
5.16.1 Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Princeton University Company Overview
5.17.1 Princeton University Pipeline Products & Ongoing Clinical Trials Overview
5.18 Rowiak GmbH Company Overview
5.18.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.19 Spire Corp Company Overview
5.19.1 Spire Corp Pipeline Products & Ongoing Clinical Trials Overview
5.20 Stroma Medical Corp Company Overview
5.20.1 Stroma Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.21 University of Bern Company Overview
5.21.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview
5.22 University of Calgary Company Overview
5.22.1 University of Calgary Pipeline Products & Ongoing Clinical Trials Overview
5.23 Visioneering Technologies Inc Company Overview
5.23.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Ophthalmic Lasers- Recent Developments
6.1 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec
6.2 May 11, 2017: ZEISS: Significant Growth in Revenue and Earnings
6.3 May 10, 2017: LENSAR Awards Teleon Surgical European Distributor Contract
6.4 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17
6.5 May 08, 2017: ZEISS Appoints New Fellow
6.6 May 08, 2017: Dr. Stephen S. Lane joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy
6.7 May 05, 2017: LENSAR Receives FDA Clearances for Laser Cataract Platform Integration With OCULUS Pentacam Tomographers
6.8 May 05, 2017: BIOLASE Announces Management Change
6.9 May 04, 2017: IRIDEX Announces Presentation Of Data Demonstrating Safety And Efficacy Of Micropulse Technology At Upcoming Industry Conferences
6.10 May 03, 2017: IRIDEX Announces First Quarter 2017 Financial Results
6.11 May 03, 2017: BIOLASE Reports 2017 First Quarter Results
6.12 Apr 25, 2017: Novartis delivered sales growth across all divisions as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued
6.13 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million
6.14 Mar 21, 2017: Dr. Tom Tooma Performs ReLEx SMILE Procedures for Correction of Myopia in Orange County
6.15 Mar 21, 2017: Dieter Kurz Confirmed as Chairman of the Supervisory Boards at SCHOTT and ZEISS
6.16 Mar 13, 2017: BIOLASE Names James D. Surek Vice President Sales, Americas
6.17 Mar 08, 2017: BIOLASE Reports 2016 Full Year and Fourth Quarter Results
6.18 Mar 08, 2017: IRIDEX Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial Outlook
6.19 Mar 01, 2017: BIOLASE Names Mark J. Nelson Chief Financial Officer
6.20 Feb 28, 2017: Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting
6.21 Feb 27, 2017: Ellex Medical Lasers: Financial Report for Half-Year Ended 31 December 2016
6.22 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17
6.23 Feb 02, 2017: Ellex Trading Update for the Six Months Ended 31 December 2016
6.24 Jan 26, 2017: LENSAR Launches Streamline III to Assist Cataract Surgeons in Managing and Improving Astigmatism Treatment for Optimal Visual Outcomes
6.25 Jan 26, 2017: Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report
6.26 Jan 26, 2017: Achievement of sales milestone for COPD products
6.27 Jan 25, 2017: Novartis delivered solid 2016 performance, with Growth Products absorbing Gleevec US LOE; innovation momentum continued; announces share buyback
6.28 Jan 17, 2017: Visioneering Technologies Announces Jeff Babbe as New Executive Territory Manager for Chicago, IL
6.29 Jan 09, 2017: BIOLASE Announces Management Change
6.30 Jan 09, 2017: IRIDEX Announces Preliminary Unaudited Revenues for 2016 Fourth Quarter and Full Year
6.31 Jan 06, 2017: NIDEK launches the YLC-500 Vixi Yellow Scan Laser Photocoagulator / YLC-500 Yellow Laser Photocoagulator
6.32 Dec 21, 2016: Visioneering Technologies Announces Brian Atkinson as Territory Manager for the Dallas/Ft. Worth Market
6.33 Dec 19, 2016: Lensar Strategic Restructure In Partnership With Pdl Biopharma
6.34 Dec 16, 2016: ZEISS Achieves Record Revenue and Earnings
6.35 Dec 13, 2016: Visioneering Technologies Announces Ken Gold as New Executive Territory Manager for the Baltimore-Washington, DC Area
6.36 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend
6.37 Dec 07, 2016: VTI names executive director of manufacturing and engineering
6.38 Dec 07, 2016: Visioneering Technologies Announces Ms. Rosa Lee as New Executive Director of Manufacturing & Engineering
6.39 Dec 01, 2016: Compact Navilas Laser System 577s Receives U.S. FDA Clearance
6.40 Nov 29, 2016: Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda
6.41 Nov 16, 2016: New Head of the ZEISS Semiconductor Manufacturing Technology Business Group
6.42 Nov 09, 2016: Daniel B. Polley, Ph.D., appointed Director of Lauer Tinnitus Research Center at Mass. Eye and Ear
6.43 Nov 08, 2016: BIOLASE Reports 2016 Third Quarter and Nine-Month Results
6.44 Nov 03, 2016: IRIDEX Reports 2016 Third Quarter, Nine-Month Results
6.45 Oct 25, 2016: Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters
6.46 Oct 18, 2016: New laser eye procedure receives FDA approval - something to SMILE about!
6.47 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer
6.48 Oct 12, 2016: Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago
6.49 Oct 11, 2016: IRIDEX Announces Preliminary Revenues for 2016 Third Quarter
6.50 Oct 04, 2016: Zecotek Announces Preliminary Revenue for Fiscal 2016
6.51 Sep 14, 2016: ZEISS receives US FDA Approval for VisuMax SMILE vision correction procedure, the latest advancement in laser eye surgery
6.52 Sep 13, 2016: FDA approves VisuMax Femtosecond Laser to surgically treat nearsightedness
6.53 Aug 26, 2016: Ellex awarded $2.5m Federal Government Grant
6.54 Aug 26, 2016: Ellex Reports Full Year FY16 Audited Results
6.55 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery
6.56 Aug 04, 2016: IRIDEX Reports 2016 Second Quarter, Six-Month Results
6.57 Aug 01, 2016: BIOLASE Reports 2016 Second Quarter and Six-Month Results
6.58 Jul 28, 2016: Ellex Reports Trading Update for the Year Ended 30 June 2016
6.59 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization
6.60 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board
6.61 Jul 19, 2016: Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects
6.62 Jul 11, 2016: IRIDEX Announces Atabak Mokari Will Be Chief Financial Officer And VP Corporate Development
6.63 Jul 06, 2016: U.S. patent trial and appeal board grants ZEISS' petition and institutes IPR against NPE patent holder AMI
6.64 Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Ophthalmic Lasers - Pipeline Products by Stage of Development
Table 2: Ophthalmic Lasers - Pipeline Products by Segment
Table 3: Ophthalmic Lasers - Pipeline Products by Territory
Table 4: Ophthalmic Lasers - Pipeline Products by Regulatory Path
Table 5: Ophthalmic Lasers - Pipeline Products by Estimated Approval Date
Table 6: Ophthalmic Lasers - Ongoing Clinical Trials
Table 7: Ophthalmic Lasers Companies - Pipeline Products by Stage of Development
Table 8: Ophthalmic Lasers - Pipeline Products by Stage of Development
Table 9: 3D-Micromac AG Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Excimer Laser System - Product Status
Table 11: Excimer Laser System - Product Description
Table 12: Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: ALLEGRETTO EX-400 Laser - Product Status
Table 14: ALLEGRETTO EX-400 Laser - Product Description
Table 15: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 16: TECHNOLAS TENEO 317 Excimer Laser - Product Status
Table 17: TECHNOLAS TENEO 317 Excimer Laser - Product Description
Table 18: Bausch & Lomb Inc - Ongoing Clinical Trials Overview
Table 19: TECHNOLAS TENEO 317 Excimer Laser - A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIK
Table 20: Bausch + Lomb Technolas Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Customlens - Product Status
Table 22: Customlens - Product Description
Table 23: Customshape - Product Status
Table 24: Customshape - Product Description
Table 25: Belkin Laser Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 26: BELKIN Laser - Glaucoma - Product Status
Table 27: BELKIN Laser - Glaucoma - Product Description
Table 28: Belkin Laser Ltd - Ongoing Clinical Trials Overview
Table 29: BELKIN Laser - Glaucoma - Direct Selective Laser Trabeculoplasty (DSLT) in Open Angle Glaucoma (OAG): A Randomized Controlled Trial
Table 30: Biolase, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 31: YSGG Waterlase Laser - Presbyopia - Product Status
Table 32: YSGG Waterlase Laser - Presbyopia - Product Description
Table 33: Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview
Table 34: IRay Stereotactic Radiotherapy System - Product Status
Table 35: IRay Stereotactic Radiotherapy System - Product Description
Table 36: CV Laser Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Multipurpose Ophthalmic Laser - Product Status
Table 38: Multipurpose Ophthalmic Laser - Product Description
Table 39: Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Integre Pro Scan - Product Status
Table 41: Integre Pro Scan - Product Description
Table 42: IOPtima Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 43: IOPtiMate - Product Status
Table 44: IOPtiMate - Product Description
Table 45: Lensar Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: LensAR Laser System - Presbyopia - Product Status
Table 47: LensAR Laser System - Presbyopia - Product Description
Table 48: LumiThera, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 49: LT-300 LED - Product Status
Table 50: LT-300 LED - Product Description
Table 51: LumiThera, Inc. - Ongoing Clinical Trials Overview
Table 52: LT-300 LED - A Double-masked, Randomized, Sham-controlled, Parallel Group, Single-center Study to Assess the Safety and Efficacy of Photobiomodulation in Subjects with Dry Age-related Macular Degeneration
Table 53: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Corneal Flap Slicer - Product Status
Table 55: Corneal Flap Slicer - Product Description
Table 56: Michigan State University Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Adaptive Laser System - Product Status
Table 58: Adaptive Laser System - Product Description
Table 59: MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 60: FLIM - Product Status
Table 61: FLIM - Product Description
Table 62: Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 63: NAVEX Quest - Product Status
Table 64: NAVEX Quest - Product Description
Table 65: Princeton University Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Presbyopia Correction Device - Product Status
Table 67: Presbyopia Correction Device - Product Description
Table 68: Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 69: LenSurgeon - Presbyopia Reversal - Product Status
Table 70: LenSurgeon - Presbyopia Reversal - Product Description
Table 71: Spire Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Fiber Laser Instrument - Eye Surgery - Product Status
Table 73: Fiber Laser Instrument - Eye Surgery - Product Description
Table 74: Stroma Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Stroma Ophthalmic Device - Eye Color - Product Status
Table 76: Stroma Ophthalmic Device - Eye Color - Product Description
Table 77: University of Bern Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Integrated Computer Assisted Retinal Laser Photocoagulation System - Product Status
Table 79: Integrated Computer Assisted Retinal Laser Photocoagulation System - Product Description
Table 80: University of Calgary Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Opthalmic Laser Device - Product Status
Table 82: Opthalmic Laser Device - Product Description
Table 83: Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 84: LASIK Device - Product Status
Table 85: LASIK Device - Product Description
Table 86: Glossary

List of Figures
Figure 1: Ophthalmic Lasers - Pipeline Products by Stage of Development
Figure 2: Ophthalmic Lasers - Pipeline Products by Segment
Figure 3: Ophthalmic Lasers - Pipeline Products by Territory
Figure 4: Ophthalmic Lasers - Pipeline Products by Regulatory Path
Figure 5: Ophthalmic Lasers - Pipeline Products by Estimated Approval Date
Figure 6: Ophthalmic Lasers - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3D-Micromac AG
  • Alcon Inc
  • Bausch & Lomb Inc
  • Bausch + Lomb Technolas
  • Belkin Laser Ltd
  • Biolase, Inc.
  • Carl Zeiss Meditec AG
  • CV Laser Pty Ltd
  • Ellex Medical Lasers Limited
  • IOPtima Ltd.
  • Lensar Inc
  • LumiThera, Inc.
  • Massachusetts Eye and Ear Infirmary
  • Michigan State University
  • MRC Systems GmbH
  • Nidek Co Ltd
  • Princeton University
  • Rowiak GmbH
  • Spire Corp
  • Stroma Medical Corp
  • University of Bern
  • University of Calgary
  • Visioneering Technologies Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll